UniPharma , Ltd. Profit Margin

UniPharma , Ltd. (6621.TWO) currently reports a profit margin of -45.19% as of June 2026. That compares with -18.13% in the prior-year period — down 149.3% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore UniPharma , Ltd.'s profit margin history and peer comparisons.

UniPharma , Ltd.'s profit margin decreased from -18.13% to -45.19% — a 149.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

UniPharma , Ltd.'s profit margin of -45.19% is lower than the its sector sector average of 13.23%. That is roughly 441.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but UniPharma , Ltd.'s current -45.19% should be judged against industry norms (sector average: 13.23%) and against 6621.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -45.19%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for UniPharma , Ltd., and consider following 6621.TWO for alerts when major investors trade the stock.